The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 15, 2017

Filed:

Feb. 14, 2014
Applicant:

Breathe Technologies, Inc., Irvine, CA (US);

Inventors:

Samir S. Ahmad, San Diego, CA (US);

Leonardo Alberto Baloa Welzien, Lake Forest, CA (US);

Assignee:

Breathe Technologies, Inc., Irvine, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 16/00 (2006.01); A61M 16/06 (2006.01); A61M 16/20 (2006.01); A61M 16/10 (2006.01);
U.S. Cl.
CPC ...
A61M 16/0069 (2014.02); A61M 16/0051 (2013.01); A61M 16/06 (2013.01); A61M 16/107 (2014.02); A61M 16/208 (2013.01); A61M 2016/0027 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/42 (2013.01); A61M 2205/50 (2013.01); A61M 2205/52 (2013.01); A61M 2230/18 (2013.01); A61M 2230/40 (2013.01);
Abstract

A method for detecting sleep for continuous positive airway pressure (CPAP) therapy is disclosed. Discrete values of a control signal generated by a pressure controller to regulate delivered pressure at the patient are measured over a predefined time window encompassing one or more respiratory cycles. A baseline control signal value is generated from a weighted average of the measured discrete values of the control signal. Estimates of a respiratory cycle period, an inspiration control time, and an expiration control time are then generated. Estimates of one or more secondary control signal properties for each of the respective inspiration control time and expiration control time are generated. Pressure to the patient is increased in response to an evaluation of the estimates of the one or more secondary control signal properties being indicative of the patient reaching a sleep state.


Find Patent Forward Citations

Loading…